These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 7821886

  • 21. Hypoglycemic effect of fenfluramine in insulin-treated diabetics.
    Hamet P, Verdy I, Chiasson JL, Verdy M.
    Clin Invest Med; 1986; 9(1):12-4. PubMed ID: 3514018
    [Abstract] [Full Text] [Related]

  • 22. The influence of liberal alcohol consumption on glucose metabolism in patients with type 1 diabetes: a pilot study.
    Kerr D, Penfold S, Zouwail S, Thomas P, Begley J.
    QJM; 2009 Mar; 102(3):169-74. PubMed ID: 19098076
    [Abstract] [Full Text] [Related]

  • 23. [Effect of glucosidase inhibitor, Bay g 5421 (acarbose), on the blood glucose in obese diabetic patients ty pe 2 (NIDDM) (author's transl)].
    Laube H, Fouladfar M, Aubell R, Schmitz H.
    Arzneimittelforschung; 1980 Mar; 30(7):1154-7. PubMed ID: 7191299
    [Abstract] [Full Text] [Related]

  • 24. [Transdermal administration of insulin in type II diabetics. Results of a clinical pilot study].
    Liedtke RK, Sorger M, Merk F, Vetter H.
    Arzneimittelforschung; 1990 Aug; 40(8):884-6. PubMed ID: 2242080
    [Abstract] [Full Text] [Related]

  • 25. Effects of acarbose, an alpha-glucosidase inhibitor (Bay G 5421), on orally loaded glucose, maltose and sucrose and on blood glucose control in non-insulin-dependent diabetics.
    Hayakawa T, Noda A, Kondo T, Okumura N.
    Nagoya J Med Sci; 1985 Jan; 47(1-2):35-41. PubMed ID: 3887176
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [The early breakfast--an unknown pitfall in the treatment of type-I diabetes mellitus].
    Renner R, Piwernetz K, Hepp KD.
    Dtsch Med Wochenschr; 1988 Aug 26; 113(34):1322-5. PubMed ID: 3044724
    [Abstract] [Full Text] [Related]

  • 29. Beneficial effects of acarbose on daily plasma glucose profile and cataract development in sand rats.
    Madar Z, Hazan A, Pollack A.
    Eye (Lond); 1994 Aug 26; 8 ( Pt 3)():353-6. PubMed ID: 7958047
    [Abstract] [Full Text] [Related]

  • 30. Studies on juvenile--type diabetes in children. Assessment of control under treatment with constant and variable doses of insulin with or without addition of biguanides.
    Schatz H, Winkler G, Jonatha EM, Pfeiffer EF.
    Diabete Metab; 1975 Dec 26; 1(4):211-20. PubMed ID: 1234581
    [Abstract] [Full Text] [Related]

  • 31. Meal intolerance in type 1 diabetes mellitus: influence of time interval between insulin therapy and meal intake.
    MacGillivray MH, Mills BJ, Voorhess ML.
    J Med; 1984 Dec 26; 15(5-6):417-35. PubMed ID: 6399521
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide, HB419 and HB420, in non insulin-dependent (type 2) diabetes.
    Scheen AJ, Jaminet C, Luyckx AS, Lefebvre PJ.
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb 26; 25(2):70-6. PubMed ID: 3104218
    [Abstract] [Full Text] [Related]

  • 33. [Effect of acarbose on injection-eating interval in type I diabetes. Preliminary contribution].
    Sailer D, Gossner L, Schönfuss I.
    Fortschr Med; 1992 Sep 20; 110(26):479-80. PubMed ID: 1398403
    [Abstract] [Full Text] [Related]

  • 34. [Effects of nifedipine on carbohydrate metabolism in the non-insulin dependent diabetic].
    Abadie E, Villette JM, Gauville C, Tabuteau F, Fiet J, Passa P.
    Diabete Metab; 1985 Jun 20; 11(3):141-6. PubMed ID: 3896885
    [Abstract] [Full Text] [Related]

  • 35. Effects of combination of zinc and vitamin A supplementation on serum fasting blood sugar, insulin, apoprotein B and apoprotein A-I in patients with type I diabetes.
    Shidfar F, Aghasi M, Vafa M, Heydari I, Hosseini S, Shidfar S.
    Int J Food Sci Nutr; 2010 Mar 20; 61(2):182-91. PubMed ID: 20151940
    [Abstract] [Full Text] [Related]

  • 36. Effect of acarbose on glycemic control, serum lipids and lipoproteins in type 2 diabetes.
    Mughal MA, Memon MY, Zardari MK, Tanwani RK, Ali M.
    J Pak Med Assoc; 2000 May 20; 50(5):152-6. PubMed ID: 11242714
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus.
    Coniff RF, Shapiro JA, Seaton TB, Bray GA.
    Am J Med; 1995 May 20; 98(5):443-51. PubMed ID: 7733122
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.